Mónica Angélica
López Rodríguez
Profesor/a Asociado/a en CC. de la Salud
Publicacións (47) Publicacións de Mónica Angélica López Rodríguez
2024
-
Characterization of the plasma proteomic profile of Fabry disease: Potential sex- and clinical phenotype-specific biomarkers
Translational Research, Vol. 269, pp. 47-63
-
Monitoring and integrated care coordination of patients with alpha-mannosidosis: A global Delphi consensus study
Molecular Genetics and Metabolism, Vol. 142, Núm. 4
2023
-
Oral Sodium Chloride in the Prevention of Contrast-Associated Acute Kidney Injury in Elderly Outpatients: The PNIC-Na Randomized Non-Inferiority Trial
Journal of Clinical Medicine, Vol. 12, Núm. 8
-
Screening for late-onset Pompe disease in Internal Medicine departments in Spain
Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1
2022
-
Hereditary Hemorrhagic Telangiectasia: Genetics, Pathophysiology, Diagnosis, and Management
Journal of Clinical Medicine, Vol. 11, Núm. 17
-
Understanding the ecosystem of patients with lysosomal storage diseases in Spain: a qualitative research with patients and health care professionals
Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1
2021
-
Manejo clínico odontológico de un paciente con mucopolisacaridosis tipo III (Síndrome de Sanfilippo)
Científica dental: Revista científica de formación continuada, Vol. 18, Núm. 5, pp. 25-33
2020
-
Aortitis in the setting of catastrophic antiphospholipid syndrome in a patient with systemic lupus erythematosus
Lupus, Vol. 29, Núm. 9, pp. 1126-1129
-
Consideraciones bucodentales en pacientes con síndrome de Morquio
Científica dental: Revista científica de formación continuada, Vol. 17, Núm. 2, pp. 27-34
2019
-
Clinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospital
Leukemia and Lymphoma, Vol. 60, Núm. 14, pp. 3442-3448
2018
-
Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis
Journal of Inherited Metabolic Disease, Vol. 41, Núm. 6, pp. 1225-1233
-
Computerized registry of patients with hemorrhagic hereditary telangiectasia (RiHHTa Registry) in Spain: Objectives, methods, and preliminary results
Revista Clinica Espanola, Vol. 218, Núm. 9, pp. 468-476
-
Fabry disease in the Spanish population: Observational study with detection of 77 patients
Orphanet Journal of Rare Diseases, Vol. 13, Núm. 1
-
Transición desde la asistencia pediátrica a la adulta en pacientes con mucopolisacaridosis
Revista Clinica Espanola, Vol. 218, Núm. 1, pp. 17-21
-
Treatment in Fabry disease
Revista Clinica Espanola
2017
-
Clinical characteristics of adult patients with inborn errors of metabolism in Spain: A review of 500 cases from university hospitals
Molecular Genetics and Metabolism Reports, Vol. 10, pp. 92-95
-
Differences between agalsidase α and agalsidase β in the treatment of Fabry disease
Medicina Clinica
-
Efficacy of laronidase therapy in patients with mucopolysaccharidosis type I who initiated enzyme replacement therapy in adult age. A systematic review and meta-analysis
Molecular Genetics and Metabolism, Vol. 121, Núm. 2, pp. 138-149
2016
-
Proceso de transición de la asistencia pediátrica a la adulta en pacientes con errores congénitos del metabolismo. Documento de consenso
Medicina Clinica, Vol. 147, Núm. 11, pp. 506.e1-506.e7
2013
-
Late optic neuropathy in propionic acidemia following surgical intervention
Journal of Neuro-Ophthalmology